Azelis in the news

Azelis's Food & Nutrition team received two awards at the Fi India 2026 Innovative Product Showcase for their Lactofree-lite Milkshake and CheesyFit Dip, demonstrating their formulation expertise.

UBS Group AG reduced its indirect holdings in Azelis Group NV below the 3% transparency threshold on August 18, 2026, due to a disposal of financial instruments.

Degroof Petercam raised Azelis' price target to 14.00 euros on strong Q2 EBITA and improved outlook, despite concerns over debt and inflation.

Azelis reported a return to growth in the first half of 2026, with increased revenue and net profit driven by positive pricing and strategic acquisitions.

Azelis has made 51 acquisitions globally, focusing on diversified chemicals, biopharma outsourcing, and food distributors, with its most recent acquisition being Distona in September 2025.

Kepler Cheuvreux raised Azelis' price target to 12.00 euros due to Q2 growth, but maintained a Hold rating over concerns about recovery quality and acquisition returns.

Azelis' stock is recovering from a downturn, facing the challenge of re-establishing organic growth after its acquisition-driven expansion slowed and investor selling pressure lifted.

UBS Group AG crossed the 3% ownership threshold in Azelis Group NV on June 24, 2026, combining shares and financial instruments.

Azelis Group is navigating fluctuating analyst price targets, declaring dividends, undergoing board changes, and executing strategic acquisitions amidst mixed financial results.

Kepler Cheuvreux upgraded Azelis to 'Hold' with an increased price target, noting recovery from lows but maintaining caution due to competition, past acquisitions, and debt.

The Bel20 index dropped half a percent due to Argenx's stock decline and AI investment doubts, despite gains in real estate and Azelis.

Azelis and Arxada have expanded their partnership to distribute industrial biocides and coatings additives in France, enhancing market presence and technical support for customers.

Azelis Group's stock has seen recent short-term gains but significant long-term declines, with analysts currently valuing the company as undervalued at –12.48 per share.

Azelis expands its partnership with Arxada in France, distributing industrial biocides and coating additives to bolster its presence in the CASE and Chemicals sectors.

Azelis will present new nutraceutical formulations, including an award-nominated low-temperature gummy, at Vitafoods Europe 2026.

Gimv acquired a 5% stake in Azelis, a chemical distributor, aiming to support its long-term strategic growth.

Gimv Anchor has acquired a 5% stake in Azelis, following the exit of former shareholder EQT.

Azelis exceeded first-quarter expectations with stronger-than-anticipated EBITA and better gross margin despite a decline in Asia-Pacific.

Azelis is expected to post weak Q1 results due to soft demand and tough comparisons, with analysts foreseeing a gradual recovery and potential benefits from geopolitical events.

This article from 'De Belegger' lists 5 key moments to watch this week, mentioning Adobe and Azelis, and includes disclaimers about content reliability and reproduction rights.